Allergy battle could be won in five years, says scientist

Jul 12, 2006

Allergies such as asthma, eczema and hay fever could be snuffed out within five years thanks to pioneering work at The University of Manchester.

Researchers, working with colleagues at St George’s, University of London, are developing drugs designed to stop allergens from entering the body, so rendering them harmless.

Professor David Garrod said the research – recently shortlisted for the Northwest Regional Development Agency’s Bionow Project of the Year – takes a completely new approach to the treatment and prevention of allergies.

“The technology is based on our earlier discovery of how allergens, the substances that cause allergy, enter the body through the surface layer of cells that protect the skin and the tubes of the lungs,” he said.

“Allergens from pollen or house dust mites are inhaled and then dissolve the binding material between the cells that form these protective linings; they can then enter the body by passing between the cells to cause an allergic response.

“The drugs we are developing – called Allergen Delivery Inhibitors (ADIs) – are designed to disable these allergens so they can no longer eat through the protective cell layer and block the allergic reaction before it occurs.

“The effect will be like avoiding allergens altogether. Removing carpets and rigorous cleaning of homes are established ways to avoid allergens, but they are only partially effective because their effects do not ‘travel’ with allergy sufferers.

“ADIs promise to be significantly better because taking a medicine is easier than rigorous housework and pills are portable.”

Professor Garrod, who is based within Manchester’s Faculty of Life Sciences, said work on the first ADI chemical was well advanced and potential drugs could enter clinical trials as early as 2010.

If successful, the drug would treat established symptoms already found in adult sufferers and, in due course, could be used to prevent allergies in children.

“Prevention of allergies has never before been possible,” said Professor Garrod. “Current medicines don’t act against the allergen at this early stage – they only ease the symptoms – so the development of these ADIs would be a major breakthrough in our fight against allergies.”

The study has already received nearly £450,000 from the Wellcome Trust but up to £3 million will be needed to develop the drugs to the clinical-trials stage.

Professor Garrod is now seeking investment to take the research to the next stage of development and a potential $26 billion market.

Source: University of Manchester

Explore further: US appeals court upholds delay in Alzheimer's drug swap

Related Stories

Ecuador breaks Guinness reforestation record

5 hours ago

Ecuador broke the world record for reforestation Saturday, as thousands of people pitched in to plant 647,250 trees in a single day, President Rafael Correa said.

Turkey delays 4G tender after Erdogan confusion

5 hours ago

Turkey has delayed its planned tender for 4G mobile technology licences, reports said Saturday, after President Recep Tayyip Erdogan sowed confusion by saying the country should skip straight to 5G technology.

Polysis is marketing a plastic that turns to clay

14 hours ago

Polysis is showing a plastic that can turn to clay when heated, according to a story on DigInfo TV. Polysis is described as a specialist developer of polyurethane resins and resin products, and they are marketing haplafreely, presented with a lower- ...

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

11 hours ago

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

School scoliosis screening has sustained effectiveness

12 hours ago

(HealthDay)—School scoliosis screening can have sustained clinical effectiveness in identifying patients with adolescent idiopathic scoliosis, according to a study published in the May 1 issue of The Sp ...

AMA: avoiding distress in medical school

13 hours ago

(HealthDay)—Understanding the key drivers underlying medical students' distress can help address the issues and enhance student well-being, according to an article published by the American Medical Association.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.